Thu, Mar 28, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

Three hedge funds lost nearly $3bn as Valeant tanks

Wednesday, March 16, 2016

Komfie Manalo, Opalesque Asia:

Three hedge fund managers lost nearly $3bn as shares of Valeant Pharmaceuticals dropped 52% Tuesday, data compiled by Bloomberg showed. Ruane Cunniff & Goldfarb, which manages Sequoia Fund, was the biggest holder of the drug maker’s shares, lost $1.26bn.

William Ackman, whose Pershing Square Capital Management is the biggest hedge funds investor at Valeant with 21.6 million common shares, lost an estimated $767m on paper. John Paulson’s Paulson & Co. gave up nearly $471m. The report said the losses were estimated on the assumption that the investors continue to hold on to their number of shares listed in their latest regulatory filings.

The drop in Valeant shares was prompted by the company’s decision to cut its revenue forecast for 2016. The drug maker lost more than 80% of its share values from an August peak and dropped more than 60% so far this year.

"As the largest shareholder of Valeant, our own credibility as investors has been damaged by this saga," Sequoia’s co-managers Robert Goldfarb and David Poppe wrote in their year-end letter to shareholders on Feb. 22, Bloomberg added.

Valeant adds hedge fund executive, 2 others to board

Last week, Valeant has added t......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1